S100A8 and S100A9 Are Associated with Colorectal Carcinoma Progression and Contribute to Colorectal Carcinoma Cell Survival and Migration via Wnt/β-Catenin Pathway

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Duan, Liang ^a   Wu, Rui ^a   Ye, Liwei ^a   Wang, Haiyan ^a   Yang, Xia ^a   Zhang, Yunyuan ^a   Chen, Xian ^a   Zuo, Guowei ^a   Zhang, Yan ^a   Weng, Yaguang ^a   Luo, Jinyong ^a   Tang, Min ^a   Shi, Qiong ^a   He, Tongchuan ^b   Zhou, Lan ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CALGRANULIN A; CALGRANULIN B; MATRILYSIN; WNT PROTEIN;

AGED; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CARCINOMA CELL; CELL DIFFERENTIATION; CELL MIGRATION; CELL SURVIVAL; CELL VIABILITY; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; EMBRYO; FEMALE; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MMP7 GENE; ONCOGENE C MYC; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GENE; WESTERN BLOTTING; WNT SIGNALING PATHWAY;

AGED; BETA CATENIN; CALGRANULIN A; CALGRANULIN B; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HEK293 CELLS; HUMANS; MALE; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-MYC; RECOMBINANT PROTEINS; UP-REGULATION; WNT SIGNALING PATHWAY;

EID: 84876878662     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062092     Document Type: Article

References (77)

1. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
2. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, et al. (2010) Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116: 544-573.
3. Goyette J, Geczy CL, (2011) Inflammation-associated S100 proteins: new mechanisms that regulate function. Amino Acids 41: 821-842.
4. Roth J, Vogl T, Sorg C, Sunderkotter C, (2003) Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol 24: 155-158.
5. Manitz MP, Horst B, Seeliger S, Strey A, Skryabin BV, et al. (2003) Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol Cell Biol 23: 1034-1043.
6. Arai K, Yamada T, Nozawa R, (2000) Immunohistochemical investigation of migration inhibitory factor-related protein (MRP)-14 expression in hepatocellular carcinoma. Med Oncol 17: 183-188.
7. Arai K, Teratani T, Nozawa R, Yamada T, (2001) Immunohistochemical investigation of S100A9 expression in pulmonary adenocarcinoma: S100A9 expression is associated with tumor differentiation. Oncol Rep 8: 591-596.
8. Arai K, Takano S, Teratani T, Ito Y, Yamada T, et al. (2008) S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast. Curr Cancer Drug Targets 8: 243-252.
9. Ito Y, Arai K, Nozawa R, Yoshida H, Hirokawa M, et al. (2009) S100A8 and S100A9 expression is a crucial factor for dedifferentiation in thyroid carcinoma. Anticancer Res 29: 4157-4161.
10. Stulik J, Osterreicher J, Koupilova K, Knizek, Macela A, et al. (1999) The analysis of S100A9 and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma: the S100A9 and S100A8 positive cells underlie and invade tumor mass. Electrophoresis 20: 1047-1054.
11. Ang CW, Nedjadi T, Sheikh AA, Tweedle EM, Tonack S, et al. (2010) Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells. Carcinogenesis 31: 1541-1551.
12. Donato R, (2003) Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 60: 540-551.
13. Donato R, (2001) S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33: 637-668.
14. Kerkhoff C, Nacken W, Benedyk M, Dagher MC, Sopalla C, et al. (2005) The arachidonic acid-binding protein S100A8/A9 promotes NADPH oxidase activation by interaction with p67phox and Rac-2. FASEB J 19: 467-469.
15. Ghavami S, Chitayat S, Hashemi M, Eshraghi M, Chazin WJ, et al. (2009) S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis. Eur J Pharmacol 625: 73-83.
16. Nakatani Y, Yamazaki M, Chazin WJ, Yui S, (2005) Regulation of S100A8/A9 (calprotectin) binding to tumor cells by zinc ion and its implication for apoptosis-inducing activity. Mediators Inflamm 2005: 280-292.
17. Yui S, Nakatani Y, Hunter MJ, Chazin WJ, Yamazaki M, (2002) Implication of extracellular zinc exclusion by recombinant human calprotectin (MRP8 and MRP14) from target cells in its apoptosis-inducing activity. Mediators Inflamm 11: 165-172.
18. Ghavami S, Rashedi I, Dattilo BM, Eshraghi M, Chazin WJ, et al. (2008) S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J Leukoc Biol 83: 1484-1492.
19. Turovskaya O, Foell D, Sinha P, Vogl T, Newlin R, et al. (2008) RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis 29: 2035-2043.
20. Hermani A, De Servi B, Medunjanin S, Tessier PA, Mayer D, (2006) S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp Cell Res 312: 184-197.
21. Wu R, Duan L, Ye L, Wang H, Yang X, et al. (2013) S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway. Int J Oncol 42: 1001-1010.
22. Ichikawa M, Williams R, Wang L, Vogl T, Srikrishna G, (2011) S100A8/A9 activate key genes and pathways in colon tumor progression. Mol Cancer Res 9: 133-148.
23. Li C, Li S, Jia C, Yang L, Song Z, et al. (2012) Low concentration of S100A8/9 promotes angiogenesis-related activity of vascular endothelial cells: bridges among inflammation, angiogenesis, and tumorigenesis?. Mediators Inflamm 2012: 248574.
24. Atallah M, Krispin A, Trahtemberg U, Ben-Hamron S, Grau A, et al. (2012) Constitutive neutrophil apoptosis: regulation by cell concentration via S100 A8/9 and the MEK-ERK pathway. PLoS One 7: e29333.
25. Fodde R, Brabletz T, (2007) Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 19: 150-158.
26. Elzagheid A, Buhmeida A, Korkeila E, Collan Y, Syrjanen K, et al. (2008) Nuclear beta-catenin expression as a prognostic factor in advanced colorectal carcinoma. World J Gastroenterol 14: 3866-3871.
27. Wanitsuwan W, Kanngurn S, Boonpipattanapong T, Sangthong R, Sangkhathat S, (2008) Overall expression of beta-catenin outperforms its nuclear accumulation in predicting outcomes of colorectal cancers. World J Gastroenterol 14: 6052-6059.
28. Major MB, Camp ND, Berndt JD, Yi X, Goldenberg SJ, et al. (2007) Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. Science 316: 1043-1046.
29. Major MB, Roberts BS, Berndt JD, Marine S, Anastas J, et al. (2008) New regulators of Wnt/beta-catenin signaling revealed by integrative molecular screening. Sci Signal 1: a12.
30. Vermeulen L, De Sousa EMF, van der Heijden M, Cameron K, de Jong JH, et al. (2010) Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 12: 468-476.
31. Baryawno N, Sveinbjornsson B, Eksborg S, Chen CS, Kogner P, et al. (2010) Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth. Cancer Res 70: 266-276.
32. Bikkavilli RK, Malbon CC, (2009) Mitogen-activated protein kinases and Wnt/beta-catenin signaling: Molecular conversations among signaling pathways. Commun Integr Biol 2: 46-49.
33. Filipek A, (2006) S100A6 and CacyBP/SIP- two proteins discovered in ehrlich ascites tumor cells that are potentially involved in the degradation of beta-catenin. Chemotherapy 52: 32-34.
34. Schneider G, Filipek A, (2011) S100A6 binding protein and Siah-1 interacting protein (CacyBP/SIP): spotlight on properties and cellular function. Amino Acids 41: 773-780.
35. Ning X, Sun S, Zhang K, Liang J, Chuai Y, et al. (2012) S100A6 protein negatively regulates CacyBP/SIP-mediated inhibition of gastric cancer cell proliferation and tumorigenesis. PLoS One 7: e30185.
36. Deol YS, Nasser MW, Yu L, Zou X, Ganju RK, (2011) Tumor-suppressive effects of psoriasin (S100A7) are mediated through the beta-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells. J Biol Chem 286: 44845-44854.
37. Zhou L, He XD, Cui QC, Zhou WX, Qu Q, et al. (2008) Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma. Cancer Lett 264: 209-217.
38. You L, Xu LL, Guo YY, Zou ZY, Li YY, et al. (2011) Prokaryotic expression, purification and identification of GST-human S100A9 fusion protein. Chinese Journal of Biochemical Pharmaceutics 32: 253-256.
39. He TC, Zhou S, da CL, Yu J, Kinzler KW, et al. (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95: 2509-2514.
40. Wu K, Yang Q, Mu Y, Zhou L, Liu Y, et al. (2012) Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/beta-catenin signaling. Int J Oncol 41: 292-298.
41. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, et al. (1998) Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512.
42. Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T, (1999) beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 155: 1033-1038.
43. Heizmann CW, Fritz G, Schafer BW, (2002) S100 proteins: structure, functions and pathology. Front Biosci 7: d1356-d1368.
44. Schafer BW, Wicki R, Engelkamp D, Mattei MG, Heizmann CW, (1995) Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of the S100 calcium-binding protein family. Genomics 25: 638-643.
45. El-Rifai W, Moskaluk CA, Abdrabbo MK, Harper J, Yoshida C, et al. (2002) Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res 62: 6823-6826.
46. Seth A, Kitching R, Landberg G, Xu J, Zubovits J, et al. (2003) Gene expression profiling of ductal carcinomas in situ and invasive breast tumors. Anticancer Res 23: 2043-2051.
47. Luo A, Kong J, Hu G, Liew CC, Xiong M, et al. (2004) Discovery of Ca2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene 23: 1291-1299.
48. Shen J, Person MD, Zhu J, Abbruzzese JL, Li D, (2004) Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res 64: 9018-9026.
49. Cross SS, Hamdy FC, Deloulme JC, Rehman I, (2005) Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 46: 256-269.
50. Carlsson H, Petersson S, Enerback C, (2005) Cluster analysis of S100 gene expression and genes correlating to psoriasin (S100A7) expression at different stages of breast cancer development. Int J Oncol 27: 1473-1481.
51. Hermani A, Hess J, De Servi B, Medunjanin S, Grobholz R, et al. (2005) Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. Clin Cancer Res 11: 5146-5152.
52. Srikrishna G, (2012) S100A8 and S100A9: new insights into their roles in malignancy. J Innate Immun 4: 31-40.
53. Qin F, Song Y, Li Z, Zhao L, Zhang Y, et al. (2010) S100A8/A9 induces apoptosis and inhibits metastasis of CasKi human cervical cancer cells. Pathol Oncol Res 16: 353-360.
54. Ghavami S, Kerkhoff C, Chazin WJ, Kadkhoda K, Xiao W, et al. (2008) S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. Biochim Biophys Acta 1783: 297-311.
55. Ghavami S, Eshragi M, Ande SR, Chazin WJ, Klonisch T, et al. (2010) S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3. Cell Res 20: 314-331.
56. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, et al. (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97: 889-901.
57. Bienz M, Clevers H, (2000) Linking colorectal cancer to Wnt signaling. Cell 103: 311-320.
58. Markowitz SD, Bertagnolli MM, (2009) Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 361: 2449-2460.
59. Gavert N, Ben-Ze'ev A, (2007) beta-Catenin signaling in biological control and cancer. J Cell Biochem 102: 820-828.
60. Klaus A, Birchmeier W, (2008) Wnt signalling and its impact on development and cancer. Nat Rev Cancer 8: 387-398.
61. Sack U, Stein U (2009) Wnt up your mind- intervention strategies for S100A4-induced metastasis in colon cancer. Gen Physiol Biophys 28 Spec No Focus: F55-F64.
62. Kolligs FT, Bommer G, Goke B, (2002) Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion 66: 131-144.
63. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, et al. (2002) The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111: 241-250.
64. Han J, Gao B, Jin X, Xu Z, Li Z, et al. (2012) Small interfering RNA-mediated downregulation of beta-catenin inhibits invasion and migration of colon cancer cells in vitro. Med Sci Monit 18: R273-R280.
65. Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, et al. (2009) A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Gastroenterology 137: 165-175.
66. Ehrchen JM, Sunderkotter C, Foell D, Vogl T, Roth J, (2009) The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 86: 557-566.
67. Kallberg E, Vogl T, Liberg D, Olsson A, Bjork P, et al. (2012) S100A9 interaction with TLR4 promotes tumor growth. PLoS One 7: e34207.
68. Loser K, Vogl T, Voskort M, Lueken A, Kupas V, et al. (2010) The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells. Nat Med 16: 713-717.
69. Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, et al. (2007) Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 13: 1042-1049.
70. Hsieh HL, Schafer BW, Sasaki N, Heizmann CW, (2003) Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays. Biochem Biophys Res Commun 307: 375-381.
71. Hermani A, Hess J, De Servi B, Medunjanin S, Grobholz R, et al. (2005) Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. Clin Cancer Res 11: 5146-5152.
72. Xiong F, Leonov S, Howard AC, Xiong S, Zhang B, et al. (2011) Receptor for advanced glycation end products (RAGE) prevents endothelial cell membrane resealing and regulates F-actin remodeling in a beta-catenin-dependent manner. J Biol Chem 286: 35061-35070.
73. Bikkavilli RK, Malbon CC, (2009) Mitogen-activated protein kinases and Wnt/beta-catenin signaling: Molecular conversations among signaling pathways. Commun Integr Biol 2: 46-49.
74. Thornton TM, Pedraza-Alva G, Deng B, Wood CD, Aronshtam A, et al. (2008) Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation. Science 320: 667-670.
75. Bikkavilli RK, Feigin ME, Malbon CC, (2008) G alpha o mediates WNT-JNK signaling through dishevelled 1 and 3, RhoA family members, and MEKK 1 and 4 in mammalian cells. J Cell Sci 121: 234-245.
76. Caverzasio J, Manen D, (2007) Essential role of Wnt3a-mediated activation of mitogen-activated protein kinase p38 for the stimulation of alkaline phosphatase activity and matrix mineralization in C3H10T1/2 mesenchymal cells. Endocrinology 148: 5323-5330.
77. Du Q, Geller DA, (2010) Cross-Regulation Between Wnt and NF-kappaB Signaling Pathways. For Immunopathol Dis Therap 1: 155-181.